10/1 12:15-13:35（201）
Satellite Symposium (III)
-- BMS
GT1b in Taiwan, Maximizing Treatment Benefit of DAA in the Real World
| Time | Topic | Speaker | Moderator |
|---|---|---|---|
| Opening |
Ding-Shinn Chen 陳定信
National Taiwan University Hospital 台大醫院
|
||
| Clinical risk stratification in HCV patients: When and in Whom to initiate treatment |
Mei-Hsuan Lee 李美璇
National Yang-Ming University 陽明大學
|
Wan-Long Chuang 莊萬龍
Kaohsiung Medical University Hospital 高雄醫學大學附設醫院
|
|
| Overview of DCV/ASV clinical outcome in high risk GT1b patients from Asian real-world experience |
Yi-Hsiang Huang 黃怡翔
Taipei Veterans General Hospital 台北榮民總醫院
|
Wan-Long Chuang 莊萬龍
Kaohsiung Medical University Hospital 高雄醫學大學附設醫院
|
|
| Taiwan real-world case sharing – I : DCV/ASV in cirrhotic GT1b patients |
I-Shyan Sheen 沈一嫻
Linkou Chang Gung Memorial Hospital 林口長庚醫院
|
Jia-Horng Kao 高嘉宏
National Taiwan University Hospital 台大醫院
|
|
| Taiwan real-world case sharing – II : DCV/ASV in IFN-experienced GT1b patients |
Tsung-Hui Hu 胡琮輝
Kaohsiung Chang Gung Memorial Hospital 高雄長庚醫院
|
Jia-Horng Kao 高嘉宏
National Taiwan University Hospital 台大醫院
|
|
| Discussion | All speakers |
Jia-Horng Kao 高嘉宏
National Taiwan University Hospital 台大醫院
|
|
| Closing |
Ding-Shinn Chen 陳定信
National Taiwan University Hospital 台大醫院
|
||